As of 09-Oct-2026
4QFY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 1.1B
12MFY26: Rs 4.1B (+8.7%)
Net profit
Rs 92.0M
12MFY26: Rs 472M (+1527.6%)
EPS
Rs 7.62
12MFY26: Rs 39.02 (+1603.9%)
DPS
Rs 0.00
12MFY26: Rs 0.00
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
9.07M (75.00%)
Free Float shares
3.02M (25.00%)
Market Cap
4.35B
#12 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to OTSU by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| CPHL Citi Pharma | 64.76 | Rs 14.6B | 19.1x | 5.5% |
| FEROZ Ferozsons Laboratories | 328.26 | Rs 14.6B | 15.1x | 1.2% |
| MACTER Macter International | 249.15 | Rs 11.4B | 16.3x | 0.8% |
| BFBIO BF Biosciences | 124.18 | Rs 10.9B | 17.3x | - |
| OTSU Otsuka Pakistan (this stock) | 359.78 | Rs 4.2B | 9.0x | - |
| IBLHL IBL HealthCare | 41.12 | Rs 4B | 18.6x | - |
| LIVEN Liven Pharma | 30.37 | Rs 3.4B | - | - |
Otsuka Pakistan Limited (the Company) was incorporated in Pakistan in the month of February 1988 as a public limited company under the repealed Companies Ordinance, 1984 ((now Companies Act, 2017 (the Act)). The Company is engaged in the manufacturing, marketing and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods and medical equipment. The Company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan. Otsuka Pakistan Limited (OTSU) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is marked Shariah-compliant on the KMI screening.
Otsuka Pakistan Limited (the Company) was incorporated in Pakistan in the month of February 1988 as a public limited company under the repealed Companies Ordinance, 1984 ((now Companies Act, 2017 (the Act)). The Company is engaged in the manufacturing, marketing and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods and medical equipment. The Company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan.
Otsuka Pakistan Limited (OTSU) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare OTSU with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
